Felipe Dal-Pizzol is an expert in Biochemistry at Universidade do Extremo Sul Catarinense (Brazil). As of October 2026, ScienceLeadR ranks Felipe Dal-Pizzol in the top 1% of experts worldwide for Coronavirus Infections, COVID-19 and Pneumonia. Felipe Dal-Pizzol has authored 533 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 1 of them ongoing. SLR score: 1,949 (community average: 125). How the SLR is computed.

LeadR Profile

1 949 ScienceLeadR Reputation 1949
Network Map

Biochemistry

Subspecialties: Critical Care - Neurology - Psychiatry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026

Source: PubMed

Universidade do Extremo Sul Catarinense

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 533

Citations

Citations: 24 735 1st author: 17 Last author: 163 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Lung-derived proteinopathy: A new framework for peripheral contributions to neurodegeneration.
PMID 42955863 — blood-brain barrier, cells, extracellular vesicles, tauopathies, lung, blood, brain, central nervous system, amyloid, nervous system
Neural Regen Res20260
Infections Acquired in the ICU Among Cancer and Other Immunosuppressed Patients: A Nationwide Cohort Study.
PMID 42895439 — incidence, hematologic neoplasms, neoplasms, cohort studies, proportional hazards models, intensive care units, immunosuppression therapy, infections
Crit Care Med20260
Proteins as Regulators of Metabolic Changes in Sepsis: Alterations in Body Fluids, Immune Cells, and Organs through the Eyes of Proteomics.
PMID 42695867 — eye, cells, lipoproteins, phenotype, sepsis, proteomics, proteome
J Proteome Res20260
Sepsis, endemic and emerging infectious diseases: converging concepts and clinical implications.
PMID 42685734 — mortality, income, sepsis, diagnosis, communicable diseases, emerging, therapeutics, communicable diseases
Lancet Infect Dis Top journal20260
Associations Between Neuromuscular Fatigue, Anxiety, and Peripheral Biomarkers of Neuronal Injury, Inflammation, and Mitochondrial Dysfunction in Treatment-Naïve Relapsing-Remitting Multiple Sclerosis.
PMID 42642873 — brain-derived neurotrophic factor, sclerosis, genes, multiple sclerosis, serum, neurons, phosphopyruvate hydratase, homeostasis, stress, physiological, inflammasomes, oxidative stress, biomarkers, fatigue, nerve growth factors, therapeutics, multiple sclerosis, relapsing-remitting
Brain Behav20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2 Study Director: 1

By phase:

N/A 7
Phase 2 5
Phase 3 5
Phase 2/Phase 3 1

By status:

Completed 14
Unknown 2
Active not recruiting 1
Terminated 1

By type:

Interventional 15
Observational 3

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 3
multicentric5to9 2
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
PRactice of VENTilation in Patients With ARDS Due to COVID 19 vs Pneumonia
NCT05650957 — lung, infant, newborn, acute lung injury, lung injury, covid-19, pneumonia, intensive care units, ventilation, respiratory distress syndrome, respiratory distress syndrome, newborn, infections
N/AActive not recruiting2022

LeadR Networks

Main global connection map